| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3350283 | Human Immunology | 2013 | 7 Pages |
Interleukin (IL)-21 may affect both T-cell and B-cell responses and was suggested to be involved in response to HBV infection. This study explored IL21rs907715 and rs2221903 and IL21R T-83C and rs3093301 polymorphisms and serum IL-21 and IgE levels in 395 patients with chronic HBV infection, 75 HBV infection resolvers and 174 healthy controls. IL21R T-83C was not polymorphic in the study populations. IL21 rs2221903 AG was less frequent in HBV patients than in resolvers (p < 0.001, OR = 0.364, 95% CI = 0.211–0.629) or in controls (p = 0.017, OR = 0.589, 95% CI = 0.381–0.911). IL21R rs3093301 TT was more frequent in HBV patients than in controls [p value after Bonferroni correction (pc) = 0.022, OR = 1.908, 95% CI = 1.158–3.142] and more frequent in resolvers than in controls (pc = 0.010, OR = 2.965, 95% CI 1.375–6.392). The carriage of IL21 rs2221903 AG/IL21R rs3093301 CT + IL21 rs2221903 AG/IL21R rs3093301 TT was less frequent in patients than in resolvers (pc = 0.007, OR = 0.236, 95% CI = 0.096–0.579) and more frequent in resolvers than in controls (pc = 0.014, OR = 4.354, 95% CI = 1.660–11.420). IL21 rs2221903 was, by interaction with IL21R rs3093301, associated with serum IL-21 and IgE levels in HBV patients. It is suggested that IL21 rs2221903 and IL21R rs3093301 polymorphisms may, independently or interactively, affect the susceptibility to and/or persistence of HBV infection potentially through altering IL-21 and IgE production.
